Effect of Alirocumab on Coronary Atheroma Volume in Japanese Patients With Acute Coronary Syndrome ― The ODYSSEY J-IVUS Trial ―
Alirocumab
Atheroma
Intravascular Ultrasound
DOI:
10.1253/circj.cj-19-0412
Publication Date:
2019-08-19T22:04:01Z
AUTHORS (12)
ABSTRACT
Background:In patients with acute coronary syndrome (ACS), alirocumab reduced the risk of recurring ischemic events. ODYSSEY J-IVUS assessed effect on atheroma volume in Japanese recently hospitalized ACS and hypercholesterolemia, using intravascular ultrasound imaging analysis.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (20)
CITATIONS (58)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....